Sanofi's Oral Treatment For Sleeping Sickness Gets FDA Approval


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


  • The FDA has approved Sanofi SA's (NASDAQ:SNY) fexinidazole as the first all-oral treatment for both stages of the Trypanosoma brucei gambiense form of sleeping sickness in patients six years of age and older and weighing at least 20 kg.
  • Sleeping sickness is a parasitic disease transmitted by the bite of an infected tse-tse fly. 
  • Fexinidazole is indicated as a 10-day once-a-day treatment.
  • Price Action: SNY shares are down 1.79% at $51.06 during the market session on the last check Monday.
  • Related content: Benzinga's Full FDA Calendar.

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsHealth CareFDAGeneralBriefs